Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
3.09
+ 0.01 (+0.33%)
4:00 PM ET on Jul 22, 2016
Delayed at least 20 minutes.
Day High 3.12
Day Low 3.01
52-Week High 11.65
Volume 340,470
Print Friendly